The Clinical Benefit of Pegylated Liposomal Doxorubicin in Patients With Metastatic Breast Cancer Previously Treated With Conventional Anthracyclines: A Multicentre Phase II Trial

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Number of pages1
JournalBreast Diseases
Issue number2
StatePublished - Jul 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this